EARNEST Partners’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $171M | Buy |
|
|||||
|
2025
Q2 | $146M | Buy |
|
|||||
|
2025
Q1 | $146M | Sell |
|
|||||
|
2024
Q4 | $203M | Buy |
|
|||||
|
2024
Q3 | $203M | Sell |
|
|||||
|
2024
Q2 | $166M | Buy |
|
|||||
|
2024
Q1 | $178M | Buy |
|
|||||
|
2023
Q4 | $127M | Buy |
|
|||||
|
2023
Q3 | $126M | Buy |
|
|||||
|
2023
Q2 | $106M | Buy |
|
|||||
|
2023
Q1 | $121M | Buy |
|
|||||
|
2022
Q4 | $103M | Buy |
|
|||||
|
2022
Q3 | $96.2M | Buy |
|
|||||
|
2022
Q2 | $111M | Buy |
|
|||||
|
2022
Q1 | $108M | Buy |
|
|||||
|
2021
Q4 | $144M | Buy |
|
|||||
|
2021
Q3 | $128M | Sell |
|
|||||
|
2021
Q2 | $112M | Buy |
|
|||||
|
2021
Q1 | $95.4M | Buy |
|
|||||
|
2020
Q4 | $88.3M | Buy |
|
|||||
|
2020
Q3 | $73.8M | Buy |
|
|||||
|
2020
Q2 | $59.8M | Buy |
|
|||||
|
2020
Q1 | $43.4M | Buy |
|
|||||
|
2019
Q4 | $44.8M | Buy |
|
|||||
|
2019
Q3 | $36M | Buy |
|
|||||
|
2019
Q2 | $33.7M | Buy |
|
|||||
|
2019
Q1 | $31.4M | Sell |
|
|||||
|
2018
Q4 | $24.2M | Buy |
|
|||||
|
2018
Q3 | $32.6M | Sell |
|
|||||
|
2018
Q2 | $30.8M | Sell |
|
|||||
|
2018
Q1 | $27.3M | Sell |
|
|||||
|
2017
Q4 | $26.1M | Sell |
|
|||||
|
2017
Q3 | $25.5M | Sell |
|
|||||
|
2017
Q2 | $26.5M | Sell |
|
|||||
|
2017
Q1 | $24.6M | Sell |
|
|||||
|
2016
Q4 | $22.8M | Sell |
|
|||||
|
2016
Q3 | $21.5M | Sell |
|
|||||
|
2016
Q2 | $19.1M | Sell |
|
|||||
|
2016
Q1 | $18.6M | Buy |
|
|||||
|
2015
Q4 | $18.7M | Sell |
|
|||||
|
2015
Q3 | $18.6M | Sell |
|
|||||
|
2015
Q2 | $23.2M | Sell |
|
|||||
|
2015
Q1 | $21.2M | Sell |
|
|||||
|
2014
Q4 | $19.5M | Sell |
|
|||||
|
2014
Q3 | $19M | Sell |
|
|||||
|
2014
Q2 | $20.6M | Sell |
|
|||||
|
2014
Q1 | $22.7M | Buy |
|
|||||
|
2013
Q4 | $21.9M | Buy |
|